Coronavirus India LIVE News Updates: India Reports 13,451 New Coronavirus Cases In 24 Hours

Coronavirus Cases Live: The national COVID-19 recovery rate was recorded at 98.19 per cent, highest since March 2020, the bulletin showed.

Coronavirus India LIVE News Updates: India Reports 13,451 New Coronavirus Cases In 24 Hours

India's active caseload stands at 1,63,816 - lowest in 241 days.

New Delhi:

India reported a single-day rise of 13,451 new COVID-19 cases with which the country's active caseload stands at 1,62,661, according to the Union Health Ministry's data updated this morning.

The daily test positivity rate - number of positive cases identified per 100 - stands at 1.03%, less than 2% for last 23 days while the weekly positivity rate stands at 1.22% less than 2% for last 33 days.

The national COVID-19 recovery rate was recorded at 98.19 per cent, highest since March 2020, the bulletin showed. With 14,021 recoveries in the last 24 hours, the total recoveries in the country climbed to 3,35,97,339.

Here are the updates on coronavirus (COVID-19) cases:

Oct 27, 2021 09:37 (IST)
Oct 27, 2021 09:00 (IST)
Oct 27, 2021 08:09 (IST)
Update| Union Health Minister Mansukh Mandaviya will chair a meeting with the state health ministers today to discuss ramping up the COVID-19 vaccination drive in the country.

Oct 27, 2021 06:06 (IST)
US Panel Recommends Pfizer Covid Vaccine For Younger Children
A medical panel of US government advisors endorsed the Pfizer Covid-19 vaccine in five-to-11-year-olds Tuesday, paving the way for younger children to get their shots within weeks.

The independent experts concluded the known benefits -- both directly to kids' health but also in ending school and other disruptions -- outweighed the known risks.

After a day of presentations and debate, the final vote was 17 in favor and one abstention.
Oct 27, 2021 05:52 (IST)
No Nod For Covaxin Yet, WHO Seeks "Additional Clarifications"
The World Health Organisation's technical advisory group on Tuesday sought "additional clarifications" from Bharat Biotech for its COVID-19 vaccine Covaxin to conduct a final "risk-benefit assessment" for Emergency Use Listing of the vaccine.

The technical advisory group will now meet on November 3 for a final assessment.

Hyderabad-based Bharat Biotech, which has developed Covaxin, had submitted EOI (Expression of Interest) to the WHO on April 19 for the vaccine's Emergency Use Listing (EUL).